Physician profile
Mark Burch
NPI 1649692765
$3,131.76
in general payments reported to CMS, 2019-2025
12 companies · $421 in 2025
The $421 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $239 · 2022: $164 · 2023: $728 · 2024: $1,580 · 2025: $421.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,768 · Food and Beverage: $960.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,768.46 |
| Food and Beverage | $960.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $1,580.20 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $763.68 | 2021-2025 | Iovera, Zilretta |
| Zynex Medical, INC. | $196.34 | 2025 | Nexwave |
| Pacira Therapeutics, INC. | $165.68 | 2021 | |
| Biotissue Holdings INC. | $133.03 | 2025 | |
| Horizon Therapeutics Plc | $79.06 | 2022 | |
| Depuy Synthes Sales INC. | $78.86 | 2022-2025 | Monovisc, Va-Lcp |
| Stryker Corporation | $53.13 | 2021 | |
| Dynasplint Systems INC. | $24.34 | 2022 | |
| Heron Therapeutics, INC. | $22.90 | 2022 | |
| Fidia Pharma USA INC. | $19.61 | 2025 | Hymovis, Triluron |
| Takeda Pharmaceuticals U.S.A., INC. | $14.93 | 2025 | Hyqvia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Burch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.